Could your gut bacteria predict implant infections after breast cancer surgery?

NCT ID NCT05020574

Recruiting now Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how antibiotics change the bacteria in the gut and breast tissue after mastectomy with implant reconstruction. Researchers will collect samples from 200 women to see if certain bacteria are linked to infections. The goal is to better understand infection risks, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cephalexin (Keflex)
What this could lead to: If successful, this could help doctors predict and prevent implant infections after mastectomy by understanding the role of bacteria.
What could go wrong: This is an early-stage study focused on feasibility, not treatment. It may not lead to changes in care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma inherited disease susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER FEMALE GENETIC PREDISPOSITION TO DISEASE

Contacts and locations

Show contact details

Locations

University of California, San Francisco
RECRUITING

San Francisco, California, 94143, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.